Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31

Eur Urol. 2016 Dec;70(6):e168-e169. doi: 10.1016/j.eururo.2016.05.028. Epub 2016 May 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abiraterone Acetate*
  • Androstenes
  • Humans
  • Male
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms, Castration-Resistant
  • Taxoids

Substances

  • Androstenes
  • Taxoids
  • Prostate-Specific Antigen
  • Abiraterone Acetate